Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 74/100

Termination Rate

21.1%

8 terminated out of 38 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

50%

8 of 16 completed with results

Key Signals

8 with results67% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (10)
P 1 (8)
P 2 (8)
P 3 (1)

Trial Status

Completed16
Terminated8
Active Not Recruiting5
Unknown4
Recruiting3
Not Yet Recruiting2

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT06486506Recruiting

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

NCT07560410Phase 1Not Yet RecruitingPrimary

Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)

NCT04650594Not ApplicableCompleted

Functional Outcomes of Knee Protheses for Malignant Tumours of Bone

NCT04307914Not ApplicableActive Not Recruiting

Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases

NCT06562673Phase 1Completed

Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma

NCT03160274Recruiting

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

NCT02880319Phase 2Active Not RecruitingPrimary

Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone

NCT06582849Not ApplicableCompletedPrimary

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

NCT06522165Active Not Recruiting

Pediatric Oncological Orthopaedic Reconstruction

NCT05131815Not ApplicableCompleted

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

NCT04974008Phase 2Active Not RecruitingPrimary

Osteosarcoma Maintenance Therapy With OST31-164

NCT04028479Completed

The Registry of Oncology Outcomes Associated with Testing and Treatment

NCT03678883Phase 2Active Not Recruiting

9-ING-41 in Patients with Advanced Cancers

NCT00020267Phase 1Completed

Vaccine Therapy in Treating Patients With Metastatic Cancer

NCT00019630Phase 1Completed

Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

NCT04842071Phase 3RecruitingPrimary

18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment

NCT04310410Phase 1Completed

Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis

NCT01336803Phase 2CompletedPrimary

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

NCT03525392Phase 1Terminated

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

NCT06070259Not Yet RecruitingPrimary

Insights Into Participating in Studies for Bone Cancer

Scroll to load more

Research Network

Activity Timeline